Publications - Michael F . Picco, M.D.

Back to Research Profile

1. Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol 2009 Nov; 104(11):2754-9. Epub 2009 Jul 07.
   View PubMed
2. Cangemi JR, Picco MF. Intestinal ischemia in the elderly. Gastroenterol Clin North Am 2009 Sep; 38(3):527-40.
   View PubMed
3. Picco MF, Cangemi JR. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 2009 Sep; 38(3):447-62.
   View PubMed
4. Cangemi JR, Picco MF. Intestinal ischemia in the elderly. Gastroenterol Clin North Am 2009 Sep; 38(3):527-40.
   View PubMed
5. Picco MF, Cangemi JR. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 2009 Sep; 38(3):447-62.
   View PubMed
6. Buchner A, Wolfsen H, Shahid M, Gill K, Schore A, Ghabril M, Gross S, Achem S, Raimondo M, Loeb, Picco M, DeVault K, Wallace M. ABIM Recertification Status and Colonoscopy Adenoma Detection Rates: A retrospective Study of 2011 Patients Undergoing Colonoscopy (M1049). Gastroenterology 2009 May; 136(5):A-339.
   View PubMed
7. Mahendraratnam N, Hutfless S, Dudley-Brown S, Picco M, Bayless, D. Patterns of Smoking and Risk of Hospitalization and Steroid Dependency in Ulcerative Colitis. Gastroenterology May 2009; 136(Supplement 1):A355-356.
   View PubMed
8. Edula R, Picco M. An evidence-based review of natalizumab therapy in the management of Crohn's disease. Therapeutics and Clinical Risk Management 2009(5):935-942.
   View PubMed
9. Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ, Crohn's and Colitis Foundation of America Clinical Alliance. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007 Oct; 13(10):1250-5.
   View PubMed
10. Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ. Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007 Oct; 13(10):1250-5.
    View PubMed
11. Picco MF. New studies on the role of smoking in inflammatory bowel disease: are we not beating a dead horse? Am J Gastroenterol 2007 Mar; 102(3):598-600.
    View PubMed
12. Picco MF, Krishna M, Cangemi JR, Shelton D. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis 2006 Jul; 12(7):537-42.
    View PubMed
13. Picco MF. , Krishna M. Cangemi JR, Shelton D Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis Inflam Bowel Dis 2006; 12:537-42.
14. Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol 2005 Jul; 100(7):1547-9.
    View PubMed
15. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003 Sep; 9(5):281-9.
    View PubMed
16. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003 Feb; 98(2):363-8.
    View PubMed
17. Lukens FJ, Loeb DS, Machicao VI, Achem SR, Picco MF. Colonoscopy in octogenarians: A prospective outpatient study. Am J Gastroenterol 2002 Jul; 97(7):1722-5.
    View PubMed
18. Scolapio JS, Picco MF, Tarrosa VB. Enteral versus parenteral nutrition: The patient's preference. JPEN J Parenter Enteral Nutr 2002 Jul-Aug; 26(4):248-50.
    View PubMed
19. Picco MF. Crohn's disease: rational management. Consultant 2002 Feb; 42(2):185-8, 191-4, 197.
20. Picco MF. Crohn Disease: A rational approach to management. Drug Benefit Trends 2002; 14(Suppl. A):25-33.
21. Picco MF, Goodman S, Reed J, Bayless TM. Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med 2001 Jun 19; 134(12):1124-9.
    View PubMed
22. Picco MF. Ulcerative colitis: a rational approach to management. Consultant 2001; 41(4):541-548.